Speaker illustration

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Dipak Kotecha is a Professor of Cardiology & Cardiac Imaging and Consultant Cardiologist, and has completed a prestigious National Institute for Health Research (NIHR) Fellowship. He works extensively with the ESC, including the Education Committee and the Committee for Practice Guidelines. His research focuses on the interaction of heart failure and atrial fibrillation, published in leading international journals. He supervises a number of PhD students including basic, translational and clinical science, leads an international heart failure consortium and runs controlled trials. Dipak also collaborates on major European grants in this field, with an interest in trial methodology, robust statistical evaluation, big data approaches and novel technology. He is the Chief Investigator for the NIHR-funded DaRe2THINK programme (national, healthcare-embedded, innovation trial) and the ESC's STEEER-AF (six-country, cluster-randomised, educational intervention) trial.

Chronic heart failure - pharmacotherapy 2

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session type: Moderated ePosters


ESC Rene Laennec Lecture on Clinical Cardiology

Event: ESC Congress 2019

Topic: Atrial Fibrillation (AF)

Session type: Special Session


Clinical Case Corner 4 - Have you seen this before? Rare presentations

Event: Heart Failure 2019

Topic: Other

Session type: Clinical Case Posters


Atrial fibrillation and HFpEF - Just twins?

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session type: Symposium


Atrial fibrillation management

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session type: Guidelines in Practice


Sinus rhythm is better than atrial fibrillation: the “rate vs. rhythm” studies revisited in the era of ablation


Topic: Atrial fibrillation (AF)

Session type: Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb